-
HEOR Theater - Applying Analytics to RWD: Real-World and Advanced Analytics, Missing Data and Predictive Modeling
11:00AM - 11:45AM EDT
-
Signal - Episode 2
Join us virtually on June 25 at the second Signal Series event that will focus on a difference between bringing a new “drug” to market, and bringing a new outcome to market – it will discuss a new vantage point from which to see, think and take advantage of emergent opportunities through new system vision for a rapidly changing healthcare context .
-
Real World Oncology in China: Unique Opportunities to Drive Improved Patient Access and Outcomes
-
How to Improve Participatory Decision Making in HTA
-
13-14 July: Introduction to Machine Learning Methods
This course gives an overview of basic machine learning concepts and provides an introduction to a few commonly used machine learning techniques and their practical applications in healthcare and pharmaceutical outcomes research.
-
Current Healthcare Funding Models, Challenges and Opportunities in the Middle East
-
Signal - Episode 3
Join us virtually on July 15 at the third Signal Series event to engage with NICE—The National Institute for Health and Care Excellence, United Kingdom, as the NICE leaders discuss the Institute’s plans to remain at the forefront of anticipating and rapidly evaluating existing and new technologies including digital health technologies, driving future research agenda and developing leading capabilities for routine use of real world evidence.
-
27-28 July: Advanced Decision Modeling for Health Economic Evaluations
During this course, the key aspects and new developments of decision modeling for economic analysis will be considered. How models can be made probabilistic to capture parameter uncertainty (including rationale, choosing parameter distributions, and types of uncertainty) will be covered.
-
2-5 August: Introduction to Health Economics and Outcomes Research
This course is designed to teach clinicians and new researchers how to incorporate health economics into study design and data analysis.
-
11-12 August: Applied Cost-Effectiveness Modeling with R
This course is designed to teach clinicians and new researchers how to incorporate health economics into study design and data analysis.
-
Use of External Controls for Oncology RWE Studies to Enhance Development and Accelerate Knowledge of New Treatments
-
ISPOR Educational Webinar: The Health Preference Research Landscape - Preference Information, Methods, and Use
-
31 August: Developing Decision-Grade Real-World Evidence
In this course, participants will be guided through a hands-on analysis of real-world data (RWD) to develop decision-grade real-world evidence (RWE) that could be used to support an indication expansion.
-
Innovations in Value Communication: Optimizing Payer Engagement at the Local Level
11:00AM - 12:00PM EST
-
Embedded Clinical Trials: Understanding the Opportunities and Challenges for Real-World Evidence Generation
11:00AM - 12:00PM EST
-
HEOR Theater - Making the most of the NICE methods updates to optimize evidence generation and global HTA strategy
10:00AM - 10:45AM EST
-
HEOR Theater - Health Technology Assessment in 2030: How Methods, Technology and Data will Change the Way Drugs are Reimbursed
12:00PM - 12:45PM EST
-
HEOR Theater - Using Item Banks to Build Condition Specific Static Short Form Outcome Measures
1:00PM - 1:45PM EST
-
27-28 September: Causal Inference and Causal Diagrams in Big, Real-World Observational Data and Pragmatic Trials
There is significant and growing interest among both the payers and producers of medical products for arrangements that involve a “pay-for-performance” or “risk-sharing” element. These payment schemes involve a plan by which the performance of the product is tracked in a defined patient population over a specified period of time and the level of reimbursement is tied by formula to the outcomes achieved.
-
Health Preference Research in the Context of Gene Therapy in Rare Diseases